39 results on '"Isabel, Hernández"'
Search Results
2. Interaction of neuropsychiatric symptoms with APOE e4 and conversion to dementia in MCI patients in a memory clinic
3. Gender and sex bias in clinical trial recruitment in Alzheimer's disease: Findings from Fundació ACE
4. P1‐540: NON‐SCHEDULED CONSULTATIONS CAN HELP TO IDENTIFY HIGHLY DEMANDING DEMENTIA PATIENTS
5. O5‐04‐01: A RARE GENETIC VARIANT IN THE PLCG2 GENE IS ASSOCIATED WITH A REDUCED RISK OF ALL MAJOR TYPES OF DEMENTIA AND AN INCREASED RISK TO REACH AN EXTREMELY OLD AGE
6. P1‐298: CEREBROSPINAL FLUID AND PLASMA LEVELS OF LYSOPHOSPHATIDIC ACIDS (LPAS) ASSOCIATE WITH CEREBROSPINAL FLUID Aβ‐42 AND P‐TAU
7. [P4–322]: ARE THERE DIFFERENCES IN THE OPINION OF PATIENTS WITH ALZHEIMER DISEASE AND THEIR CAREGIVERS ABOUT HAVING SUPPORT FROM A SERVICE ROBOT AT HOME?
8. [P3–233]: CORRELATIONS BETWEEN PLASMA AND BRAIN BETA‐AMYLOID LEVELS IN INDIVIDUALS WITH SUBJECTIVE COGNITIVE DECLINE: THE FUNDACIÓ ACE HEALTHY BRAIN INITIATIVE (FACEHBI)
9. [P3–102]: GENETIC RISK FOR SCHIZOPHRENIA AND PSYCHOSIS IN ALZHEIMER DISEASE
10. [O1–13–06]: THE SPANISH VERSION OF FACE‐NAME ASSOCIATIVE MEMORY EXAM (S‐FNAME) PERFORMANCE IS RELATED TO AMYLOID BURDEN IN SUBJECTIVE COGNITIVE DECLINE
11. P2-127: ETIOPATHOLOGICAL ROLE OF THE MAPT H1/H2 HAPLOTYPE IN ALZHEIMER'S DISEASE
12. P2‐087: Genetic Determinants of Alzheimer's Disease Progression: Exploratory Analysis of International Genomics of Alzheimer Project (IGAP) Genetic Markers in MMSE Rate of Decline and GDS
13. P1‐321: White Matter Microstructure Disruption Could Be an Early Phenomenon in The Pathophysiology of Preclinical Alzheimer's Disease: FundaciÓ ACE Healthy Brain Initiative
14. P2‐141: FundaciÓ ACE Healthy Brain Initiative: A Study of Cognition and Biomarkers in Individuals with Subjective Cognitive Decline
15. P2‐399: RAMCIP PROJECT, A ROBOTIC ASSISTANT TO SUPPORT ALZHEIMER'S DISEASE PATIENTS AT HOME: A NOVEL APPROACH IN CAREGIVING
16. P1‐096: Impact of Recruitment Methods in Subjective Cognitive Decline
17. P2‐283: An interdisciplinary portrait of dementia: The reality of barcelona, spain
18. P3‐196: Cognitive composites and prodromal Alzheimer's disease
19. O4‐05‐04: A four‐center study on the effect of polygenic risk score on cerebrospinal fluid markers and memory decline in mild cognitive impairment patients
20. O4‐04‐04: TOWARD FINE MAPPING AND FUNCTIONAL CHARACTERIZATION OF GENOME‐WIDE ASSOCIATION STUDY‐IDENTIFIED LOCUS RS74615166 (TRIP4) FOR ALZHEIMER'S DISEASE
21. P1‐046: ROLE OF PLD3 RARE VARIANTS IN EUROPEAN SPORADIC ALZHEIMER'S DISEASE PATIENTS
22. O4‐11‐05: A PHASE II STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PLASMA REPLACEMENT WITH 5% ALBUMIN IN BETA‐AMYLOID PEPTIDE CLEARANCE IN CEREBROSPINAL FLUID, AND ITS EFFECTS IN PATIENTS WITH MILD‐MODERATE ALZHEIMER'S DISEASE
23. P4–138: Identification of misdiagnosed frontotemporal dementia using apolioprotein genotype and linear discriminant analysis
24. P3‐403: Longitudinal neuroimaging analysis in Alzheimer's disease after plasma exchange with 5% Grifols albumin (Albutein®)
25. P1‐337: Results of a phase II study of plasma exchange with 5 percent albumin (Albutein®) in Alzheimer's disease patients
26. P4‐244: Exploratory analysis of seven confirmed risk factors for Alzheimer's disease with disease progression
27. P4‐243: ATP5H/KCTD2 locus and Alzheimer's disease: An etiological link between key brain functions and dementia
28. P4‐248: Molecular evaluation of the ubiquitin 2 gene PXX domain in familial frontotemporal dementia patients
29. Genetic association of complement receptor 1 polymorphism rs3818361 in Alzheimer's disease
30. P2‐448: Peripheral amyloid‐beta mobilization with the intravenous immunoglobulin Flebogamma DIF® in Alzheimer's disease patients
31. P1‐185: 'Open House' Screening Program to Identify Cognitive Impairment Among Community‐Dwelling Middle‐Aged/Elderly People
32. P1‐431: Neuroimage in Alzheimer's disease: Results after plasma exchange with Human Albumin Grifols ®
33. P4‐117: An Angiotensin‐Converting Enzyme (ACE) polymorphism is associated with intracerebral hemorrhage recurrences in Cerebral Amyloid Angiopathy patients
34. P4‐099: Molecular analysis of GOLPH2 gene SNPs in Alzheimer's disease
35. P4‐104: Estrogen receptor alpha (ESR1) gene variants are associated to Alzheimer's disease in Spanish population
36. P4‐355: An exploratory study of the potential utility of plasma exchange with 5 percent human albumin Grifols ® in the treatment of Alzheimer's disease (AD)
37. P2–269: Brain SPET quantification in incipient Alzheimer (DAT) dementia: Comparison between SPM and neurogam
38. P3-259: GAB2 gene does not modify Alzheimer's risk in Spanish APOE E4 carriers
39. Design of a comprehensive Alzheimer’s disease clinic and research center in Spain to meet critical patient and family needs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.